Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Sikha Singh"'
Publikováno v:
International Journal of Neonatal Screening, Vol 9, Iss 4, p 68 (2023)
Newborn screening (NBS) for Severe Combined Immunodeficiency (SCID) by measurement of T-cell receptor excision circles (TRECs) successfully identifies newborns with SCID and severe T-cell lymphopenia, as intended. At the same time, NBS programs face
Externí odkaz:
https://doaj.org/article/352960223ff94e52ba0c9a5c536b2227
Publikováno v:
International Journal of Neonatal Screening, Vol 9, Iss 2, p 20 (2023)
The Recommended Uniform Screening Panel (RUSP) is the list of conditions recommended by the US Secretary of Health and Human Services for inclusion in state newborn screening (NBS). During 2010–2022, seven conditions were added to the RUSP: severe
Externí odkaz:
https://doaj.org/article/b9bc4652070e427fb07305c692ab0cb5
Publikováno v:
International Journal of Neonatal Screening, Vol 9, Iss 2, p 23 (2023)
Newborn screening (NBS) is a state or territory-based public health system that screens newborns for congenital diseases that typically do not present with clinical symptoms at birth but can cause significant mortality and morbidity if not detected o
Externí odkaz:
https://doaj.org/article/8ff2048102c74722bd7d2e95c49100af
Autor:
Sikha Singh, Michele Caggana, Carol Johnson, Rachel Lee, Guisou Zarbalian, Amy Gaviglio, Alisha Keehn, Mia Morrison, Scott J. Becker, Jelili Ojodu
Publikováno v:
International Journal of Neonatal Screening, Vol 8, Iss 2, p 28 (2022)
Newborn screening (NBS) is an essential public health service that performs screening to identify those newborns at increased risk for a panel of disorders, most of which are genetic. The goal of screening is to link those newborns at the highest ris
Externí odkaz:
https://doaj.org/article/da6acc79c2764310ae793f29bfd2934f
Autor:
Ruthanne Sheller, Jelili Ojodu, Emma Griffin, Sari Edelman, Careema Yusuf, Trey Pigg, Alissa Huston, Brian Fitzek, John G. Boyle, Sikha Singh
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Severe combined immunodeficiency (SCID) is T cell development disorders in the immune system and can be detected at birth. As of December 2018, all 53 newborn screening (NBS) programs within the United States and associated territories offer universa
Externí odkaz:
https://doaj.org/article/eec822ea3f8b4714b0f04ac5e95c3a8b
Autor:
Marci K Sontag, Joshua I Miller, Sarah McKasson, Ruthanne Sheller, Sari Edelman, Careema Yusuf, Sikha Singh, Deboshree Sarkar, Joseph Bocchini, Joan Scott, Jelili Ojodu, Yvonne Kellar-Guenther
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231050 (2020)
BackgroundNewborn screening (NBS) aims to achieve early identification and treatment of affected infants prior to onset of symptoms. The timely completion of each step (i.e., specimen collection, transport, testing, result reporting), is critical for
Externí odkaz:
https://doaj.org/article/8192fd45dafb417a885bbc8f8ac1bb09
Publikováno v:
International Journal of Neonatal Screening, Vol 7, Iss 3, p 49 (2021)
Newborn screening (NBS) follow-up programs in the United States are managed at the state level, leaving limited opportunities for collaboration across programs and coordinated resource sharing. The Newborn Screening Technical assistance and Evaluatio
Externí odkaz:
https://doaj.org/article/65e7042e3045477c87eef8119e7e82d0
Publikováno v:
International Journal of Neonatal Screening, Vol 7, Iss 3, p 33 (2021)
Newborn screening (NBS) programs identify newborns at increased risk for genetic disorders, linking these newborns to timely intervention and potentially life-saving treatment. In the United States, the Health and Human Services (HHS) Advisory Commit
Externí odkaz:
https://doaj.org/article/29eaf8a8fc2a4086817af69689d0a1f6
Publikováno v:
International Journal of Neonatal Screening, Vol 6, Iss 2, p 48 (2020)
Public health programs in the United States screen more than four million babies each year for at least 30 genetic disorders. The Health and Human Services (HHS) Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) recommends t
Externí odkaz:
https://doaj.org/article/3cc3af83d7e64e96a790207e61993900
Autor:
Yvonne Kellar-Guenther, Sarah McKasson, Kshea Hale, Sikha Singh, Marci K. Sontag, Jelili Ojodu
Publikováno v:
International Journal of Neonatal Screening, Vol 6, Iss 2, p 35 (2020)
Data were collected from 39 newborn screening (NBS) programs to provide insight into the time and factors required for implementing statewide screening for Pompe, Mucopolysaccharidosis type I (MPS I), adrenoleukodystrophy (ALD), and Spinal Muscular A
Externí odkaz:
https://doaj.org/article/ae0b5f4ac9ae454387d2f86d0185220a